Jialin Sun

820 citations
36 papers · 523 indexed · h-index 15
Topics
Nanoparticle-Based Drug Delivery (9 papers)Nanoplatforms for cancer theranostics (6 papers)Natural product bioactivities and synthesis (4 papers)
Partner nations
ChinaEgyptUnited States

In The Last Decade

Jialin Sun

34 papers receiving 512 citations

Peers

Jialin Sun
Comparison fields: 5 of 92
  • Molecular Biology 233
  • Biomedical Engineering 143
  • Biomaterials 108
  • Plant Science 88
  • Molecular Medicine 47
Replace S.R. Aravind with:
S.R. Aravind India
Xuewei Zheng China
Fatemeh Mamashli Iran
Jin Sil Lee South Korea
Qiling Chen China
Tingting Xiao China
Furkan Ayaz Türkiye
Farshad Mirzavi Iran
Jialin Sun relative to S.R. Aravind India S.R. Aravind's profile →
Citations per field
00.5×4.6×
S.R. Aravind · 1×
Citations per year

Countries citing papers authored by Jialin Sun

Since Specialization
Citations

This map shows the geographic impact of Jialin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialin Sun more than expected).

Fields of papers citing papers by Jialin Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialin Sun. The network helps show where Jialin Sun may publish in the future.

Co-authorship network of co-authors of Jialin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jialin Sun. A scholar is included among the top collaborators of Jialin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialin Sun. Jialin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 19
4 10
5 5
6 7
7 2
8 2
9 1
10 20
11 24
12 7
13 99
14 34
15 14
16 32
17
Research Progress of Pluronic as a Drug Delivery System for Reversing Multidrug Resistance of Tumors
1
18 20
19
Future Development of Platinum Anticancer Drugs
1
20 21

About Jialin Sun

Jialin Sun is a scholar working on Biomaterials, Molecular Medicine and Biotechnology, having authored 36 papers that have together received 523 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (6 papers) and Natural product bioactivities and synthesis (4 papers). The work is most often cited by research in Molecular Medicine (47 citations), Biomaterials (108 citations) and Biotechnology (35 citations). Jialin Sun has collaborated with scholars based in China, Egypt and United States. Frequent co-authors include Weinan Li, Yanhong Wang, Jia Li, Qingxia Guan, Tetsu Kawazu, Kunio Ohmiya, Chuanzhuang Zhao, Mingming Zhang, Kazuo Sakka and Qie Guo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026